Search

everythinglearnresearchcommunity

for

Search:↓

The conclusion is that oral contraceptives and antiandrogens can treat hirsutism and acne in women with cutaneous hyperandrogenism, but more research is needed for effective treatments, especially for hair loss.

The document concludes that correct diagnosis and management of PCOS are important, and more research is needed on its risks and treatments.

Some women with PCOS have CYP21 mutations and IRS1 variants, but these genetic factors are not major contributors to PCOS.

Treat hair loss with finasteride, minoxidil, or surgery; consider side effects and severity.

Finasteride treats enlarged prostate, improves urinary flow, but may cause sexual side effects.

Blocking the prolactin receptor might help treat various diseases, but more research is needed.

DHT's role in hair loss is important, but measuring its level for diagnosis is questionable.

Minoxidil effectively treats female pattern hair loss.

Existing drug dexamethasone may lower death risk in severe COVID-19 cases; more research needed for other drugs.

Finasteride effectively treats hair loss in transgender men with few side effects.

Finasteride and flutamide both reduce hair growth, but finasteride has fewer side effects.

Testosterone therapy may slightly improve sexual function in postmenopausal women, but its long-term safety is unknown.

Hair loss in women not always linked to increased oil production; other factors may be involved.

A team approach is crucial for managing PCOS, with dermatologists playing a key role.

The document concludes that new treatments are needed to better manage acne and reduce side effects related to current therapies.

Birth control pills and cyproterone acetate can help treat acne in women, especially when linked to hormonal issues.

Low and ultralow doses of flutamide can cause liver damage in young women with high androgen levels, regardless of dose or birth control use, with higher risk for those with higher BMI and liver enzyme levels before treatment.

Certain medications and maintaining adequate iron levels can help manage women's hair loss.

Girls with PCOS during adolescence have a higher risk of developing type 2 diabetes, and early treatment can help manage this risk.

The normal human prostate does not significantly affect blood DHT levels.

PCOS is a complex disorder managed by treating symptoms and requires a team of specialists.

A teenage girl with high androgen levels and PCOS developed a rare liver tumor, suggesting a possible link between high androgens and the tumor's growth.

All treatments reduce hair growth; low dose flutamide most effective with fewer side effects.

Many elderly women experience unwanted facial hair and various hair loss conditions, with treatments available for each condition.

Topical minoxidil helps treat female pattern hair loss, but more research needed for other treatments.

5α-Reductase inhibitors can help treat hair loss, acne, and prostate issues by reducing DHT levels.

Obesity increases the risk of skin infections, inflammatory conditions, and melanoma, but not basal cell carcinoma.

Spironolactone, a heart and liver drug, has new uses including cancer treatment, viral infection prevention, and skin condition improvement.

Larger ovarian size is linked to higher insulin resistance in women with PCOS.

The article concludes that correctly diagnosing systemic causes of hair loss requires a detailed clinical evaluation and a systematic diagnostic approach.